COVID19 biomarkers: What did we learn from systematic reviews?
S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …
Systemic inflammation index, disease severity, and mortality in patients with COVID-19: a systematic review and meta-analysis
AA Mangoni, A Zinellu - Frontiers in Immunology, 2023 - frontiersin.org
Introduction An excessive systemic pro-inflammatory state increases the risk of severe
disease and mortality in patients with coronavirus disease 2019 (COVID-19). However, there …
disease and mortality in patients with coronavirus disease 2019 (COVID-19). However, there …
Differences in the severity and mortality risk factors for patients hospitalized for COVID-19 pneumonia between the early wave and the very late stage of the pandemic
H Li, X Jia, Y Wang, Y Lv, J Wang, Y Zhai… - Frontiers in Medicine, 2023 - frontiersin.org
Background Since China's dynamic zero-COVID policy is cancelled on December 7, 2022,
the rapidly growing number of patients has brought a major public health challenge. This …
the rapidly growing number of patients has brought a major public health challenge. This …
Prognostic value of serum α-HBDH levels in patients with lung cancer
ZM Yuan, LH Wang, C Chen - World Journal of Surgical Oncology, 2023 - Springer
Background The purpose of our study is to investigate the expression level and prognostic
value of serum α-hydroxybutyrate dehydrogenase (α-HBDH) in lung cancer (LC) patients …
value of serum α-hydroxybutyrate dehydrogenase (α-HBDH) in lung cancer (LC) patients …
Clinical biomarker profiles reveals gender differences and mortality factors in sepsis
Z Chang, J Lu, Q Zhang, H Wu, Z Liang, X Pan… - Frontiers in …, 2024 - frontiersin.org
Background Sepsis is a major contributor to global morbidity and mortality, affecting millions
each year. Notwithstanding the decline in sepsis incidence and mortality over decades …
each year. Notwithstanding the decline in sepsis incidence and mortality over decades …
GACEMV: An ensemble learning framework for constructing COVID-19 diagnosis and prognosis models
L Sun, Y Liu, L Han, Y Chang, M Du, Y Zhao… - … Signal Processing and …, 2024 - Elsevier
The accurate prediction of the severity and prognosis of COVID-19 patients is essential in
order to select the ideal treatment plan, which can help reduce mortality rates associated …
order to select the ideal treatment plan, which can help reduce mortality rates associated …
Serum α-hydroxybutyrate dehydrogenase as a biomarker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy
J Ye, L Zheng, Z Chen, Q Wang, X Liao, X Wang, Q Wei… - BMC urology, 2024 - Springer
Purpose We aimed to determine the prognostic value of α-hydroxybutyrate dehydrogenase
(α-HBDH) in upper tract urothelial carcinoma (UTUC) patients after radical …
(α-HBDH) in upper tract urothelial carcinoma (UTUC) patients after radical …
[PDF][PDF] 中老年高血压并非重型新型冠状病毒肺炎患者的临床特征及其病程影响因素分析
沈炀， 贺彬婵， 周茜， 董高军… - 实用心脑肺 …, 2022 - boyuancaibian.oss-cn-beijing …
目的探讨中老年高血压并非重型新型冠状病毒肺炎(COVID-19) 患者的临床特征.
方法回顾性选取2021-07-22 至2021-09-03 南京市公共卫生中心收治的中老年非重型COVID …
方法回顾性选取2021-07-22 至2021-09-03 南京市公共卫生中心收治的中老年非重型COVID …
Лабораторные маркёры полиорганной патологии при тяжёлом течении и неблагоприятных исходах инфекции SARS-CoV-2 (систематический обзор …
НА Конышко, ЛИ Волынец, ГС Конышко - Журнал инфектологии, 2023 - journal.niidi.ru
Аннотация Представлены современные научно обоснованные сведения о
лабораторных параметрах пациентов с тяжёлым течением и неблагоприятными …
лабораторных параметрах пациентов с тяжёлым течением и неблагоприятными …
Elevated serum α-hydroxybutyrate dehydrogenase is an independent risk factor for survival outcomes in UTUC patients after radical nephroureterectomy
J Ye, Z Chen, X Wang, C Zhang, P Han, Q Wei, Y Bao - 2023 - researchsquare.com
Background To determine the prognostic value of α-hydroxybutyrate dehydrogenase (α-
HBDH) on survival outcomes in upper tract urothelial carcinoma (UTUC) patients after …
HBDH) on survival outcomes in upper tract urothelial carcinoma (UTUC) patients after …